Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178290 · ClinicalTrials.gov registry record · NA
Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers
A NA study of Exercise and Diet, Healthy, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 1,356
- Enrollment target
- 1
- Study location
NCT05178290: Completed NA study of Exercise and Diet, Healthy, sponsored by Arizona State University.
NCT05178290 is a NA study of Exercise and Diet, Healthy that has completed, run by Arizona State University. The registered enrollment target is 1,356 participants, below the 8,887-participant average among 57 other Exercise trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05178290, a NA study of Exercise and Diet, Healthy, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,356 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to get children safely back to school by (1) Child and Family Testing, (2) ECE Personnel Testing, and (3) Outdoor Learning via Garden Education.
Primary Outcome
Proportion of viable saliva samples obtained from children
Conditions Studied
Interventions
- BEHAVIORAL CHILD back-to-ECE COVID-19 saliva testing
- BEHAVIORAL ECE personnel back-to-ECE COVID-19 saliva screening
- BEHAVIORAL SAGE garden programming
Study Locations (1)
Arizona
- Arizona State University-Downtown Campus - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,356 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT05178290 record still lists
NCT05178290 is an interventional study that assigns participants to a tested intervention. Its 1,356 participants enrollment target places it among the larger protocols in the corpus, below the 8,887-participant average among 57 other Exercise trials with a reported enrollment target (85% lower).
The record links to 7 conditions, with Exercise appearing as the primary indexed condition, and to 3 interventions - of which CHILD back-to-ECE COVID-19 saliva testing is the first listed.
NCT05178290 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05178290 about?
NCT05178290 is a clinical study titled "Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers". This study aims to get children safely back to school by (1) Child and Family Testing, (2) ECE Personnel Testing, and (3) Outdoor Learning via Garden Education.
What is the current status of trial NCT05178290?
This trial is currently completed. It is a NA study. The enrollment target is 1,356 participants. The study started on 2021-11-22. Estimated completion is 2023-06-30.
What conditions does trial NCT05178290 study?
This clinical trial studies the following conditions: Exercise, Diet, Healthy, Child Development, Parents, Self-Control.
What interventions are being tested in trial NCT05178290?
The interventions under investigation include: CHILD back-to-ECE COVID-19 saliva testing (BEHAVIORAL), ECE personnel back-to-ECE COVID-19 saliva screening (BEHAVIORAL), SAGE garden programming (BEHAVIORAL).
Who is sponsoring clinical trial NCT05178290?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178290 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05178290's enrollment target sits among peer trials
1,356 3rd of 57 higher than 55 of 57 other Exercise trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI